Immunohistological study of mononuclear cell infiltrate in malignant gliomas (original) (raw)
References
Alexander P (1976) The functions of the macrophages in malignant disease. Annu Rev Med 27:207–224 Google Scholar
Basham T, Merrigan TC (1982) Immunoregulation by Y interferon? Nature 299:278 Google Scholar
Bertrand I, Mannen H (1960) Études des réactions vasculairés dans les astrocytomes. Rev Neurol (Paris) 102:3–19 Google Scholar
Brooks WH, Markesbery WR, Gupta GD, Roszman TL (1978) Relationship of lymphocyte invasion and survival of brain tumour patients. Ann Neurol 4:219–224 Google Scholar
Carrel S, De Tribolet N, Gross N (1982) Expression of HLADR and common acute lymphoblastic lukemia antigen on glioma cells. Eur J Immunol 12:354–357 Google Scholar
Clarkson S, Kimberley RP, Valinsky JE, Witmer M, Bussel JB, Nachman RL, Unkeless JC (1986) Blockade of clearance of immmune complexes by anti-Fcy receptor monoclonal antibody. J Exp Med 164:474–489 Google Scholar
Coakham HB, Garson JA, Brownell B, Kemshead JT (1985) Diganosis of cerebral neoplasms using monoclonal antibodies. Prog Exp Tumor Res 29:55–77 Google Scholar
Esiri MM, McGee J O'D (1986) Monoclonal antibody to macrophages (EBM11) labels macrophages and microglial cells in human brain. J Clin Pathol 39:615–621 Google Scholar
Farrar WL, Johnson HM, Farrar J (1981) Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin-2. J Immunol 126:1120–1125 Google Scholar
Fleit HB, Wirght SD, Unkeless JC (1982) Human neutrophil Fcy receptor distribution and structure. Proc Natl Acad Sci USA 79:3275–3279 Google Scholar
Fontana A, Fierz W, Wekerle H (1984) Astrocytes present myelin basic protein to encephalogenic T cell lines. Nature 307:273–276 Google Scholar
Friedman RM, Vogel SN (1983) Interferon with special emphasis on the immune system. Adv Immunol 34:97–100 Google Scholar
Gillis S, Smith KA (1977) Long term culture of tumour specific cytotoxic T cells. Nature 268:154–156 Google Scholar
Henney CS, Kuribayashi K, Kern DE, Gillis S (1981) Interleukin-2 augments natural killer cell activity. Nature 291:335–338 Google Scholar
Hofman FM, Von Hanwer RI, Dinarello CA, Mizel SB, Hinton D, Merrill J (1986) Immunoregulatory molecules and interleukin-2 receptor identified in multiple sclerosis brain. J Immunol 136:3239–3245 Google Scholar
Hogg N (1986) Factor-induced differentiation and activation of macrophages. Immunol Today 7:65–66 Google Scholar
Jacobs SK, Wilson DJ, Kornblith PL, Grimm EA (1986) Interleukin-2 or autologous lymphokine activated killer cell treatment of malignant gliomas. Cancer Res 46:2101–2104 Google Scholar
Jacobs SK, Wilson DJ, Kornblith PL, Grimm EA (1986) In vitro killing of human glioblastoma by interleukin-2 activated autologous lymphocytes. J Neurosurg 64:114–117 Google Scholar
Kernohan JW, Mabon RF, Stein JH, Adson AW (1949) A simplified classification of the gliomas. Proc Staff Meet Mayo Clin 24:71–75 Google Scholar
King DP, Jones PP (1983) Induction of Ia and H-2 antigens on a macrophage cell line by immune interferon. J Immunol 131:315–318 Google Scholar
Kril MP, Apuzzo MLJ (1983) Observation in the study of T lymphocyte subsets by monoclonal antibodies and flow cytometric analysis in intracranial neoplastic disorders. Clin Neurosurg 30:125–136 Google Scholar
Lampson LA, Hickey WF (1986) Monoclonal antibody analysis of MHC expression in human brain biopsies: tissue ranging from histologically normal to that showing different levels of glial tumour involvement. J Immunol 136:4054–4062 Google Scholar
Matthews N (1981) Production of anti-tumour cytotoxin by human monocytes. Immunology 44:135–142 Google Scholar
McKinnon KP, Chen AR, Argov S, Love B, Koren HS (1986) Cytolysis of actinomycin-d-treated target cells by cell-free supernatants from human monocytes. Immunobiology 171:26–44 Google Scholar
Morantz RA, Wood GW, Foster M, Clark M, Gollahon K (1979) Macrophages in experimental and human tumours. Studies of the macrophage content of human brain tumours. J Neurosurg 50:305–311 Google Scholar
Mørk SJ, Nyland H, Matre R, Ganz J (1985) Characterization of host mononuclear cells in gliomas. J Neuropathol Exp Neurol 44:317 (abstr) Google Scholar
Mule J, Shu S, Rosenberg SA (1985) The anti-tumour effect of lymphokine-activated killer cells and recombinant interleukin-2 in vivo. J Immunol 135:646–652 Google Scholar
Palma L, Di Lorenzo N, Guidetti B (1978) Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas: incidence, fate and relevance to prognosis in 228 operated cases. J Neurosurg 49:854–861 Google Scholar
Philip R, Epstein LB (1986) Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, Y interferon and interleukin-1. Nature 323:86–89 Google Scholar
Phillips JP, Eremin O, Anderson JR (1982) Lymphoreticular cells in human brain tumours and in normal brain. Br J Cancer 45:61–69 Google Scholar
Rayner AA, Grimm EA, Lotze MT, Wilson DJ, Rosenberg SA (1985) Lymphokine-activated killer cell phenomenon. IV. Lysis by LAK cell clones of fresh human tumour cells from autologous and multiple allogeneic tumours. JNCl 75:67–75 Google Scholar
Ridley A, Cavanagh JB (1971) Lymphocytic infiltration in gliomas: evidence of possible host resistance. Brain 94:117–124 Google Scholar
Rosenberg SA, Lotze MT, Muul L, Leitman S, Chang A, Ettinghausen SE, Matory YL, Skibber JM, Shiloni E, Vetto JT, Seipp CA, Simpson C, Reichert CM (1985) Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 313:1485–1492 Google Scholar
Schiffer D, Croveri G, Pautasso C (1974) Frequenza e significato degli infiltrati linfo-plasmacellulari nei gliomi umani. Tumori 60:177–184 Google Scholar
Stavrou D, Anzil AP, Weidenbach W, Rodt H (1977) Immunofluorescence study of lymphocytic infiltration in gliomas. Identification of T lymphocytes. J Neurol Sci 33:275–282 Google Scholar
Steeg PS, Moore RN, Johnson H, Oppenheim J (1982) Regulation of murine macrophage Ia antigen expression by a lymphokine with immune interferon activity. J Exp Med 156:1780–1793 Google Scholar
Takeuchi J, Barnard RO (1976) Perivascular lymphocytic cuffing in astrocytomas. Acta Neuropathol (Berl) 35:265–271 Google Scholar
Traugott U, Scheinberg LC, Raine CS (1985) On the presence of Ia-positive endothelial cells and astrocytes in multiple sclerosis and its relevance to antigen presentation. J Neuroimmunol 8:1–14 Google Scholar
Volc-Platzer B, Majdic O, Knapp W, Wolff K, Hinterberger W, Lechner K, Stingl G (1984) Evidence of HLADR antigen biosynthesis in human keratinocytes in disease. J Exp Med 159:1784–1789 Google Scholar
Von Hanwehr RI, Hofman FM, Taylor CR, Apuzzo MLJ (1984) Mononuclear lymphoid populations infiltrating the microenvironment of primary CNS tumours. Characterisation of cell subsets with monoclonal antibodies. J Neurosurg 60:1138–1147 Google Scholar
Werdelin O, Schevach M (1979) Role of nominal antigen and Ia antigen in the binding of antigen-specific T lymphocytes to macrophages. J Immunol 123:2779–2783 Google Scholar
Wood GW, Morantz RA (1979) Immunohistological evaluation of the lymphoreticular infiltrate in human CNS tumours. JNCI 62:485–490 Google Scholar
Woodrofe MN, Bellamy AS, Feldman M, Davison AN, Cuzner ML (1987) Immunocytochemical characterisation of the immune reaction in the central nervous system in multiple sclerosis: possible role of microglia in lesion growth. J Neurol Sci 74:135–152 Google Scholar
Yu DTY, Fu SM, Winchester J, Hunkel HG (1980) Two types of Ia-positive cells. Synthesis and exchange of Ia antigens. J Exp Med 152:89s-98s Google Scholar